Human colostrum oligosaccharides modulate major immunologic pathways of immature human intestine

Mucosal Immunology

Volumn 7, Issue 6, 2014, Pages 1326-1339

  He, Y ^a   Liu, S ^b   Leone, S ^a   Newburg, D S ^a  

^a BOSTON COLLEGE   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; MONOCYTE CHEMOTACTIC PROTEIN 1; MONOCYTE CHEMOTACTIC PROTEIN 2; OLIGOSACCHARIDE; POLYINOSINIC POLYCYTIDYLIC ACID;

ARTICLE; CELL COMMUNICATION; COLOSTRUM; CONTROLLED STUDY; EX VIVO STUDY; FETUS; GENE EXPRESSION; GENETIC TRANSCRIPTION; HISTOCOMPATIBILITY; HOMEOSTASIS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMATURITY; IMMUNOCOMPETENT CELL; IMMUNOLOGY; IMMUNOMODULATION; INTESTINE MUCOSA; NEWBORN; PROTEIN EXPRESSION; RECEPTOR GENE; SIGNAL TRANSDUCTION; TISSUE DIFFERENTIATION; TISSUE METABOLISM; TISSUE REPAIR; CELL CULTURE; CLINICAL TRIAL; CYTOLOGY; FEMALE; MUCOSAL IMMUNITY; PHYSIOLOGY; SMALL INTESTINE;

CELLS, CULTURED; COLOSTRUM; CYTOKINES; FEMALE; HUMANS; IMMUNITY, MUCOSAL; INTESTINE, SMALL; OLIGOSACCHARIDES; SIGNAL TRANSDUCTION;

EID: 84908158844     PISSN: 19330219     EISSN: 19353456     Source Type: Journal    
DOI: 10.1038/mi.2014.20     Document Type: Article

References (74)

1. Mannick, E. & Udall, J. N. Jr. Neonatal gastrointestinal mucosal immunity. Clin Perinatol 23, 287-304 (1996).
2. Bailey, M. et al. The development of the mucosal immune system pre-and post-weaning: balancing regulatory and effector function. Proc Nutr Soc 64, 451-457 (2005).
3. Rognum, T. O., Thrane, S., Stoltenberg, L., Vege, A. & Brandtzaeg, P. Development of intestinal mucosal immunity in fetal life and the first postnatal months. Pediatr Res 32, 145-149 (1992).
4. Schnabl, K. L., Van Aerde, J. E., Thomson, A. B. & Clandinin, M. T. Necrotizing enterocolitis: a multifactorial disease with no cure. World J Gastroenterol 14, 2142-2161 (2008).
5. Lin, P. W. & Stoll, B. J. Necrotising enterocolitis. Lancet 368, 1271-1283 (2006).
6. Schirbel, A. & Fiocchi, C. Targeting the innate immune system in pediatric inflammatory bowel disease. Exp Rev Gastroenterol Hepatol 5, 33-41 (2011).
7. Buescher, E. S. Anti-inflammatory characteristics of human milk: how, where, why. Adv Exp Med Biol 501, 207-222 (2001).
8. Ballard, O. & Morrow, A. L. Human milk composition: nutrients and bioactive factors. Pediatr Clin North Am 60, 49-74 (2013).
9. Kelly, D. & Coutts, A. G. Early nutrition and the development of immune function in the neonate. Proc Nutr Soc 59, 177-185 (2000).
10. Schanler, R. J., Shulman, R. J. & Lau, C. Feeding strategies for premature infants: beneficial outcomes of feeding fortified humanmilk versus preterm formula. Pediatrics 103 (6 Pt 1), 1150-1157 (1999).
11. Lucas, A. & Cole, T. J. Breast milk and neonatal necrotising enterocolitis. Lancet 336, 1519-1523 (1990).
12. Klement, E., Cohen, R. V., Boxman, J., Joseph, A. & Reif, S. Breastfeeding and risk of inflammatory bowel disease: a systematic review with metaanalysis. Am J Clin Nutr 80, 1342-1352 (2004).
13. Newburg, D. S., Ruiz-Palacios, G. M. & Morrow, A. L. Human milk glycans protect infants against enteric pathogens. Annu Rev Nutr 25, 37-58 (2005).
14. Kunz, C., Rudloff, S., Baier,W., Klein, N. & Strobel, S. Oligosaccharides in human milk: structural, functional, and metabolic aspects. Annu Rev Nutr 20, 699-722 (2000).
15. Kunz, C. & Rudloff, S. Potential anti-inflammatory and anti-infectious effects of human milk oligosaccharides. Adv Exp Med Biol 606, 455-465 (2008).
16. Naarding, M. A. et al. Lewis X component in human milk binds. J Clin Invest 115, 3256-3264 (2005).
17. Jantscher-Krenn, E. et al. The human milk oligosaccharide disialyllacto-Ntetraose prevents necrotising enterocolitis in neonatal rats. Gut 61, 1417-1425 (2012).
18. Coppa, G. V., Pierani, P., Zampini, L., Carloni, I., Carlucci, A. & Gabrielli, O. Oligosaccharides in human milk during different phases of lactation. Acta Paediatr Suppl 88, 89-94 (1999).
19. Chaturvedi, P. et al. Fucosylated human milk oligosaccharides vary between individuals and over the course of lactation. Glycobiology 11, 365-372 (2001).
20. Sumiyoshi, W. et al. Galactosyllactoses in the milk of Japanese women: changes in concentration during the course of lactation. J Appl Glycosci 51, 341-344 (2004).
21. Zarember, K. A. & Godowski, P. J. Tissue expression of human Toll-like receptors and differential regulation of Toll-like receptor mRNAs in leukocytes in response to microbes, their products, and cytokines. J Immunol 168, 554-561 (2002).
22. Humke, E. W., Shriver, S. K., Starovasnik, M. A., Fairbrother, W. J. & Dixit, V. M. ICEBERG: a novel inhibitor of interleukin-1beta generation. Cell 103, 99-111 (2000).
23. Vogel, C. &Marcotte, E. M. Insights into the regulation of protein abundance from proteomic and transcriptomic analyses. Nat Rev Genet 13, 227-232 (2012).
24. Nanthakumar, N. N., Fusunyan, R. D., Sanderson, I. & Walker, W. A. Inflammation in the developing human intestine: a possible pathophysiologic contribution to necrotizing enterocolitis. Proc Natl Acad Sci USA 97, 6043-6048 (2000).
25. Youn, B. S. et al. Molecular cloning of leukotactin-1: a novel human betachemokine, a chemoattractant for neutrophils, monocytes, and lymphocytes, and a potent agonist atCCchemokine receptors 1 and 3. J Immunol 159, 5201-5205 (1997).
26. Yang, L., Froio, R. M., Sciuto, T. E., Dvorak, A. M., Alon, R. & Luscinskas, F. W. ICAM-1 regulates neutrophil adhesion and transcellular migration of TNF-alpha-activated vascular endothelium under flow. Blood 106, 584-592 (2005).
27. Clements, J. M. et al. Two PDGF-B chain residues, arginine 27 and isoleucine 30, mediate receptor binding and activation. EMBO J 10, 4113-4120 (1991).
28. Morgunova, E., Tuuttila, A., Bergmann, U. & Tryggvason, K. Structural insight into the complex formation of latent matrix metalloproteinase 2 with tissue inhibitor of metalloproteinase 2. Proc Natl Acad Sci USA 99, 7414-7419 (2002).
29. Baggiolini, M., Walz, A. & Kunkel, S. L. Neutrophil-activating peptide-1/ interleukin 8, a novel cytokine that activates neutrophils. J Clin Invest 84, 1045-1049 (1989).
30. McCracken, V. J. & Lorenz, R. G. The gastrointestinal ecosystem: a precarious alliance among epithelium, immunity and microbiota. Cell Microbiol 3, 1-11 (2001).
31. Nanthakumar,N. et al. TheMechanism of excessive intestinal inflammation in necrotizing enterocolitis: an immature innate immune response. PLoS One 6, e17776 (2011).
32. Kuo, S., El Guindy, A., Panwala, C. M., Hagan, P. M. & Camerini, V. Differential appearance of T cell subsets in the large and small intestine of neonatal mice. Pediatr Res 49, 543-551 (2001).
33. Levy, O. Innate immunity of the newborn: basic mechanisms and clinical correlates. Nat Rev Immunol 7, 379-390 (2007).
34. Abrahamsson, T. R., Sandberg Abelius, M., Forsberg, A., Bjorksten, B. & Jenmalm, M. C. A. Th1/Th2-associated chemokine imbalance during infancy in children developing eczema, wheeze and sensitization. Clin Exp Allergy 41, 1729-1739 (2011).
35. Gartner, L. M. et al. Breastfeeding and the use of human milk. Pediatrics 115, 496-506 (2005).
36. Newburg, D. S. Neonatal protection by an innate immune system of human milk consisting of oligosaccharides and glycans. J Anim Sci 87 (Suppl 13), 26-34 (2009).
37. Goldman, A. S., Goldblum, R. M. & Hanson, L. A. Anti-inflammatory systems in human milk. Adv Exp Med Biol 262, 69-76 (1990).
38. Eiwegger, T. et al. Human milk-derived oligosaccharides and plantderived oligosaccharides stimulate cytokine production of cord blood T-cells in vitro. Pediatr Res 56, 536-540 (2004).
39. Armogida, S. A., Yannaras, N. M., Melton, A. L. & Srivastava, M. D. Identification and quantification of innate immune system mediators in human breast milk. Allergy Asthma Proc 25, 297-304 (2004).
40. Kramer,M. S. et al. Promotion of breastfeeding intervention trial (PROBIT): a randomized trial in the Republic of Belarus. JAMA 285, 413-420 (2001).
41. Hofmann, S. R. et al. Cytokines and their role in lymphoid development, differentiation and homeostasis. Curr Opin Allergy Clin Immunol 2, 495-506 (2002).
42. Takeuchi, H., Fujimoto, A., Tanaka, M., Yamano, T., Hsueh, E. & Hoon,D. S. CCL21 chemokine regulates chemokine receptor CCR7 bearing malignant melanoma cells. Clin Cancer Res 10, 2351-2358 (2004).
43. Sallusto, F.,Mackay,C. R. & Lanzavecchia,A. Selective expression of the eotaxin receptor CCR3 by human T helper 2 cells. Science 277, 2005-2007 (1997).
44. Garcia-Zepeda, E. A. et al. Human monocyte chemoattractant protein (MCP)-4 is a novel CC chemokine with activities on monocytes, eosinophils, and basophils induced in allergic and nonallergic inflammation that signals through the CC chemokine receptors (CCR)-2 and-3. J Immunol 157, 5613-5626 (1996).
45. Ahuja, S. K. & Murphy, P. M. The CXC chemokines growth-regulated oncogene (GRO) alpha, GRObeta, GROgamma, neutrophil-activating peptide-2, and epithelial cell-derived neutrophil-activating peptide-78 are potent agonists for the type B, but not the type A, human interleukin-8 receptor. J Biol Chem 271, 20545-20550 (1996).
46. Shannon, L. A., Calloway, P. A., Welch, T. P. & Vines, C. M. CCR7/CCL21 migration on fibronectin is mediated by phospholipase Cg1 and ERK1/2 in primary T lymphocytes. J Biol Chem 285, 38781-38787 (2010).
47. Meloche, S. & Pouyssegur, J. The ERK1/2 mitogen-activated protein kinase pathway as a master regulator of the G1-to S-phase transition. Oncogene 26, 3227-3239 (2007).
48. Maheshwari, A. & Zemlin, M. Ontogeny of the intestinal immune system. Immunol Infect 2, 18-26 (2006).
49. Neurath, M. F., Finotto, S. & Glimcher, L. H. The role of Th1/Th2 polarization in mucosal immunity. Nat Med 8, 567-573 (2002).
50. Kidd, P. Th1/Th2 balance: the hypothesis, its limitations, and implications for health and disease. Altern Med Rev 8, 223-246 (2003).
51. Randolph, D. A., Huang,G., Carruthers, C. J., Bromley, L. E. & Chaplin, D. D. The role of CCR7 in TH1 and TH2 cell localization and delivery of B cell help in vivo. Science 286, 2159-2162 (1999).
52. Vigne, S. et al. IL-36 signaling amplifies Th1 responses by enhancing proliferation andTh1polarization of naiveCD4 Tcells. Blood120,3478-3487(2012).
53. Shaffer, A. L., Yu, X., He, Y., Boldrick, J., Chan, E. P. & Staudt, L. M. BCL-6 represses genes that function in lymphocyte differentiation, inflammation, and cell cycle control. Immunity 13, 199-212 (2000).
54. Takatsu, K. Interleukin 5 and B cell differentiation. Cytokine Growth Factor Rev 9, 25-35 (1998).
55. Clinton, C. Development of the infant immune function and the effects of breast milk. Natural Med J 2, 3-6 (2010).
56. Kumar, V. & Sharma, A. Neutrophils: Cinderella of innate immune system. Int Immunopharmacol 10, 1325-1334 (2010).
57. Liang, S. C. et al. Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides. J Exp Med 203, 2271-2279 (2006).
58. Korn, T., Bettelli, E.,Oukka, M. & Kuchroo, V. K. IL-17 and Th17 Cells. Annu Rev Immunol 27, 485-517 (2009).
59. Maddur, M. S., Miossec, P., Kaveri, S. V. & Bayry, J. Th17 cells: biology, pathogenesis of autoimmune and inflammatory diseases, and therapeutic strategies. Am J Pathol 181, 8-18 (2012).
60. Kimura, A. & Kishimoto, T. IL-6: regulator of Treg/Th17 balance. Eur J Immunol 40, 1830-1835 (2010).
61. Dingle, B. M., Liu, Y., Fatheree, N. Y., Min, J., Rhoads, J. M. & Tran, D. Q. FoxP3() Regulatory T cells attenuate experimental necrotizing enterocolitis. PLoS One 8, e82963 (2013).
62. Weitkamp, J.-H. et al. Necrotising enterocolitis is characterised by disrupted immune regulation and diminished mucosal regulatory (FOXP3)/effector (CD4, CD8) T cell ratios. Gut 62, 73-82 (2012).
63. Hayashi, F. et al. The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5. Nature 410, 1099-1103 (2001).
64. De Miranda, J., Yaddanapudi, K., Hornig, M. & Lipkin, W. I. Astrocytes recognize intracellular polyinosinic-polycytidylic acid via MDA-5. FASEB J 23, 1064-1071 (2009).
65. Eder, C. Mechanisms of interleukin-1b release. Immunobiology 214, 543-553 (2009).
66. Sullivan, S. et al. An exclusively human milk-based diet is associated with a lower rate of necrotizing enterocolitis than a diet of human milk and bovine milk-based products. J Pediatr 156, 562-567, e561 (2010).
67. Yu, Z. T. et al. The principal fucosylated oligosaccharides of human milk exhibit prebiotic properties on cultured infant microbiota. Glycobiology 23, 169-177 (2013).
68. Yu, Z. T., Chen, C. & Newburg, D. S. Utilization of major fucosylated and sialylated human milk oligosaccharides by isolated human gut microbes. Glycobiology 23, 1281-1292 (2013).
69. Nanthakumar, N. N., Meng, D. & Newburg, D. S. Glucocorticoids and microbiota regulate ontogeny of intestinal fucosyltransferase 2 requisite for gut homeostasis. Glycobiology 23, 1131-1141 (2013).
70. Weiss, G. A. & Hennet, T. The role of milk sialyllactose in intestinal bacterial colonization. Adv Nutr 3, 483S-488S (2012).
71. Coppa,G. V., Bruni, S., Morelli, L., Soldi, S. &Gabrielli, O. The first prebiotics in humans: human milk oligosaccharides. J Clin Gastroenterol 38, S80-S83 (2004).
72. Vos, A. P. et al. Dietary supplementation of neutral and acidic oligosaccharides enhances Th1-dependent vaccination responses in mice. Pediatr Allergy Immunol 18, 304-312 (2007).
73. Newburg, D. S. et al. Innate protection conferred by fucosylated oligosaccharides of human milk against diarrhea in breastfed infants. Glycobiology 14, 253-263 (2004).
74. Crane, J. K., Azar, S. S., Stam, A. & Newburg, D. S. Oligosaccharides from human milk block binding and activity of the Escherichia coli heatstable enterotoxin (STa) in T84 intestinal cells. J Nutr 124, 2358-2364 (1994).